Nautilus Biotechnology Future Growth
Future criteria checks 2/6
Nautilus Biotechnology's earnings are forecast to decline at 11.2% per annum while its annual revenue is expected to grow at 62.1% per year. EPS is expected to decline by 7% per annum. Return on equity is forecast to be -65% in 3 years.
Key information
-11.2%
Earnings growth rate
-7.0%
EPS growth rate
| Life Sciences earnings growth | 18.8% |
| Revenue growth rate | 62.1% |
| Future return on equity | -65.0% |
| Analyst coverage | Low |
| Last updated | 01 Nov 2024 |
Recent future growth updates
Recent updates
We're Not Very Worried About Nautilus Biotechnology's (NASDAQ:NAUT) Cash Burn Rate
Jul 27
We Think Nautilus Biotechnology (NASDAQ:NAUT) Can Afford To Drive Business Growth
Feb 16Companies Like Nautilus Biotechnology (NASDAQ:NAUT) Are In A Position To Invest In Growth
Oct 22We're Not Very Worried About Nautilus Biotechnology's (NASDAQ:NAUT) Cash Burn Rate
May 25We Think Nautilus Biotechnology (NASDAQ:NAUT) Can Afford To Drive Business Growth
Feb 17Nautilus Biotechnology Q2 2022 Earnings Preview
Aug 01The Take On Nautilus Biotechnology
Jan 17Nautilus Biotechnology: Recent Selloff Provides A Fantastic Entry Point
Jan 07Nautilus Biotechnology: Tapping The Potential Of The Human Proteome
Aug 30Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 26 | -104 | -85 | -82 | 4 |
| 12/31/2025 | 5 | -97 | -79 | -76 | 5 |
| 12/31/2024 | N/A | -76 | -64 | -62 | 4 |
| 9/30/2024 | N/A | -70 | -61 | -59 | N/A |
| 6/30/2024 | N/A | -70 | -60 | -57 | N/A |
| 3/31/2024 | N/A | -67 | -58 | -55 | N/A |
| 12/31/2023 | N/A | -64 | -54 | -52 | N/A |
| 9/30/2023 | N/A | -60 | -50 | -48 | N/A |
| 6/30/2023 | N/A | -58 | -48 | -46 | N/A |
| 3/31/2023 | N/A | -57 | -49 | -46 | N/A |
| 12/31/2022 | N/A | -58 | -48 | -46 | N/A |
| 9/30/2022 | N/A | -61 | -49 | -46 | N/A |
| 6/30/2022 | N/A | -62 | -53 | -51 | N/A |
| 3/31/2022 | N/A | -58 | -48 | -45 | N/A |
| 12/31/2021 | N/A | -50 | -42 | -39 | N/A |
| 9/30/2021 | N/A | -39 | -35 | -33 | N/A |
| 6/30/2021 | N/A | -28 | -24 | -23 | N/A |
| 3/31/2021 | N/A | -21 | -19 | -18 | N/A |
| 12/31/2020 | N/A | -16 | -15 | -14 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NAUT is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: NAUT is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: NAUT is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: NAUT's revenue (62.1% per year) is forecast to grow faster than the US market (8.9% per year).
High Growth Revenue: NAUT's revenue (62.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: NAUT is forecast to be unprofitable in 3 years.